BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Angiex Initiates Patient Dosing in Phase 1 Clinical Trial of AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Cancers

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for t...

August 12, 2024 | News

NEC Bio Therapeutics and AGC Biologics Partner to Enhance Production of Personalized Cancer Vaccine

NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based D...

August 08, 2024 | News

Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...

August 07, 2024 | News

NCCN Enhances Partnership with Medlive to Expand Oncology Guidelines Access in China

United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncol...

July 31, 2024 | News

ObvioHealth Secures Strategic Investment from Guardant Health to Boost Oncology Clinical Trials

ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company ...

July 26, 2024 | News

Pfizer Opens SGD$1 Billion Green Mark Gold-Certified API Manufacturing Facility in Singapore

Invests SGD$1 billion to produce small molecule APIs for oncology, pain, and antibiotic medicines The facility is Green Mark ‘Go...

July 23, 2024 | News

QDX and Prelude Therapeutics Join Forces to Target Previously Undrugged Oncology Targets

QDX, a computational drug discovery company, announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeti...

July 23, 2024 | News

Thermo Fisher and NCI Join Forces to Accelerate Precision Medicine Trials for AML and MDS

To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: T...

July 12, 2024 | News

N-Power Medicine Partners with MSD to Expand Oncologist and Patient Access to Clinical Trials

N-Power Medicine, a company reinventing the clinical trial process, is collaborating with Merck, known as MSD outside the United States and Canada, to enab...

July 02, 2024 | News

Lilly Forms Strategic Partnership with Radionetics for GPCR-Targeted Radiopharmaceuticals

Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals Radionetics to receive $140 million upfront p...

July 02, 2024 | News

Genoks and Velsera Partner to Transform Cancer Diagnostics and Treatment in Turkey

Genoks, a leading Turkish genomics healthcare company, and Velsera, a global healthcare technology company offering a universal software platform to connec...

July 01, 2024 | News

Advancing Cancer Care: The Promise and Potential of CAR-T Therapy

In an interaction with BioPharma APAC, Anuradha Rajapakse, Senior Director for Value & Access at Gilead and Kite Oncology, This discussion...

June 28, 2024 | Interaction

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa

Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...

June 24, 2024 | News

ReviR Therapeutics and Asieris Pharmaceuticals Achieve Milestone in Cancer Treatment Collaboration

ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncolog...

June 18, 2024 | News

Stay Connected